Mycotic abdominal aortic aneurysm caused by campylobacter fetus: A case report and literature review

Hideharu Hagiya, Mitsuaki Matsumoto, Hiroshi Furukawa, Tomoko Murase, Fumio Otsuka

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Campylobacter spp. usually cause gastrointestinal infections, but among them, Campylobacter fetus is a well-known organism causing mycotic abdominal aortic aneurysm (MAAA), which requires proper surgical intervention and antibiotic therapy. We report a 65-year-old man who was successfully treated by an in situ operation using a rifampicin (RFP)-bonded J-Graft for C. fetus-induced MAAA. We performed a review of the English literature on MAAA caused by C. fetus and summarized the results of the cases (28 cases). All but 2 of the patients (92.9%) were men. Blood culture and arterial wall culture were positive in 63% and 73.1% of the cases, respectively. Aneurysm rupture was seen in half of the patients, and approximately half of those patients died. Among the 18 patients who underwent in situ graft replacement, only 1 patient (5.6%) died after surgery. Antibiotic therapy was performed for more than 1 month in most cases, and overall mortality rate was 25.9% (7 of 27 cases, 3 deaths before the operation and 4 deaths after surgery). Although extra-Anatomic bypass has been conventionally performed after complete resection of an MAAA, the utility of in situ surgery has generally been recognized. Our review suggests that the in situ operation can be a choice also in cases of C. fetus-Associated MAAA. Furthermore, our case suggested the clinical utility of a newly manufactured prosthetic graft, J-Graft, for such surgical treatment.

Original languageEnglish
Pages (from-to)1933.e7-1933.e4
JournalAnnals of Vascular Surgery
Volume28
Issue number8
DOIs
Publication statusPublished - Nov 1 2014

Fingerprint

Campylobacter fetus
Abdominal Aortic Aneurysm
Transplants
Anti-Bacterial Agents
Campylobacter
Rifampin
Aneurysm
Rupture
Therapeutics
Mortality
Infection

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Mycotic abdominal aortic aneurysm caused by campylobacter fetus : A case report and literature review. / Hagiya, Hideharu; Matsumoto, Mitsuaki; Furukawa, Hiroshi; Murase, Tomoko; Otsuka, Fumio.

In: Annals of Vascular Surgery, Vol. 28, No. 8, 01.11.2014, p. 1933.e7-1933.e4.

Research output: Contribution to journalArticle

Hagiya, Hideharu ; Matsumoto, Mitsuaki ; Furukawa, Hiroshi ; Murase, Tomoko ; Otsuka, Fumio. / Mycotic abdominal aortic aneurysm caused by campylobacter fetus : A case report and literature review. In: Annals of Vascular Surgery. 2014 ; Vol. 28, No. 8. pp. 1933.e7-1933.e4.
@article{78cb07c175c341eebf8e6f65abaa4942,
title = "Mycotic abdominal aortic aneurysm caused by campylobacter fetus: A case report and literature review",
abstract = "Campylobacter spp. usually cause gastrointestinal infections, but among them, Campylobacter fetus is a well-known organism causing mycotic abdominal aortic aneurysm (MAAA), which requires proper surgical intervention and antibiotic therapy. We report a 65-year-old man who was successfully treated by an in situ operation using a rifampicin (RFP)-bonded J-Graft for C. fetus-induced MAAA. We performed a review of the English literature on MAAA caused by C. fetus and summarized the results of the cases (28 cases). All but 2 of the patients (92.9{\%}) were men. Blood culture and arterial wall culture were positive in 63{\%} and 73.1{\%} of the cases, respectively. Aneurysm rupture was seen in half of the patients, and approximately half of those patients died. Among the 18 patients who underwent in situ graft replacement, only 1 patient (5.6{\%}) died after surgery. Antibiotic therapy was performed for more than 1 month in most cases, and overall mortality rate was 25.9{\%} (7 of 27 cases, 3 deaths before the operation and 4 deaths after surgery). Although extra-Anatomic bypass has been conventionally performed after complete resection of an MAAA, the utility of in situ surgery has generally been recognized. Our review suggests that the in situ operation can be a choice also in cases of C. fetus-Associated MAAA. Furthermore, our case suggested the clinical utility of a newly manufactured prosthetic graft, J-Graft, for such surgical treatment.",
author = "Hideharu Hagiya and Mitsuaki Matsumoto and Hiroshi Furukawa and Tomoko Murase and Fumio Otsuka",
year = "2014",
month = "11",
day = "1",
doi = "10.1016/j.avsg.2014.06.072",
language = "English",
volume = "28",
pages = "1933.e7--1933.e4",
journal = "Annals of Vascular Surgery",
issn = "0890-5096",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Mycotic abdominal aortic aneurysm caused by campylobacter fetus

T2 - A case report and literature review

AU - Hagiya, Hideharu

AU - Matsumoto, Mitsuaki

AU - Furukawa, Hiroshi

AU - Murase, Tomoko

AU - Otsuka, Fumio

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Campylobacter spp. usually cause gastrointestinal infections, but among them, Campylobacter fetus is a well-known organism causing mycotic abdominal aortic aneurysm (MAAA), which requires proper surgical intervention and antibiotic therapy. We report a 65-year-old man who was successfully treated by an in situ operation using a rifampicin (RFP)-bonded J-Graft for C. fetus-induced MAAA. We performed a review of the English literature on MAAA caused by C. fetus and summarized the results of the cases (28 cases). All but 2 of the patients (92.9%) were men. Blood culture and arterial wall culture were positive in 63% and 73.1% of the cases, respectively. Aneurysm rupture was seen in half of the patients, and approximately half of those patients died. Among the 18 patients who underwent in situ graft replacement, only 1 patient (5.6%) died after surgery. Antibiotic therapy was performed for more than 1 month in most cases, and overall mortality rate was 25.9% (7 of 27 cases, 3 deaths before the operation and 4 deaths after surgery). Although extra-Anatomic bypass has been conventionally performed after complete resection of an MAAA, the utility of in situ surgery has generally been recognized. Our review suggests that the in situ operation can be a choice also in cases of C. fetus-Associated MAAA. Furthermore, our case suggested the clinical utility of a newly manufactured prosthetic graft, J-Graft, for such surgical treatment.

AB - Campylobacter spp. usually cause gastrointestinal infections, but among them, Campylobacter fetus is a well-known organism causing mycotic abdominal aortic aneurysm (MAAA), which requires proper surgical intervention and antibiotic therapy. We report a 65-year-old man who was successfully treated by an in situ operation using a rifampicin (RFP)-bonded J-Graft for C. fetus-induced MAAA. We performed a review of the English literature on MAAA caused by C. fetus and summarized the results of the cases (28 cases). All but 2 of the patients (92.9%) were men. Blood culture and arterial wall culture were positive in 63% and 73.1% of the cases, respectively. Aneurysm rupture was seen in half of the patients, and approximately half of those patients died. Among the 18 patients who underwent in situ graft replacement, only 1 patient (5.6%) died after surgery. Antibiotic therapy was performed for more than 1 month in most cases, and overall mortality rate was 25.9% (7 of 27 cases, 3 deaths before the operation and 4 deaths after surgery). Although extra-Anatomic bypass has been conventionally performed after complete resection of an MAAA, the utility of in situ surgery has generally been recognized. Our review suggests that the in situ operation can be a choice also in cases of C. fetus-Associated MAAA. Furthermore, our case suggested the clinical utility of a newly manufactured prosthetic graft, J-Graft, for such surgical treatment.

UR - http://www.scopus.com/inward/record.url?scp=84908279423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908279423&partnerID=8YFLogxK

U2 - 10.1016/j.avsg.2014.06.072

DO - 10.1016/j.avsg.2014.06.072

M3 - Article

C2 - 25017776

AN - SCOPUS:84908279423

VL - 28

SP - 1933.e7-1933.e4

JO - Annals of Vascular Surgery

JF - Annals of Vascular Surgery

SN - 0890-5096

IS - 8

ER -